Here are four points:
1. Under the research agreement, the two companies will create precision diagnostics for pathogens and their antimicrobial resistances in infectious diseases.
2. A biotech company, bioMérieux develops in vitro diagnostics for infectious diseases.
3. bioMérieux will team up with George Weinstock, PhD, who is a Jackson Laboratory professor, Evnin Family Chair and director of microbial genomics.
4. Dr. Weinstock’s laboratory is focused on next-generation DNA sequencing and metagenomic analysis.
More articles on quality & infection control:
FDA recommends all US blood donations should be screened for Zika — 5 highlights
Bringing caregivers into the fold: 5 strategies for nurses to improve the patient experience
Mylan to offer $300 generic to EpiPen auto-injector in effort to save face: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.